Allopurinol Tablet
Product Images NDC 63187-240
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 63187-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol Tabs 2)
463-30 (Allopurinol Tabs 3)
240-30 (Allopurinol Tabs 4)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.